Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline as Adjuvant in MDD
NCT03554447Phase 2Completed
- Start
- Apr 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pentoxifylline in major depressive disorder (MDD). Started Apr 2015; status: completed.
02
Drugs
pentoxifylline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03554447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03554447.